Intravenous Anesthetic Market by Type, Product, Application, End User, and Region - Global Opportunity Analysis and Industry Forecast, Vendor Landscape, Market Growth, Trends & Forecast 2019 – 2025

According to a new market research report published by Apsters Research “Intravenous Anesthetic Market by Drug, Patient Type, End User, and Region - Global Opportunity Analysis and Industry Forecast, 2019 – 2025”, the global intravenous anesthetic market is expected to reach USD xxx million by 2025 from USD xxx million in 2018, at a CAGR of xx% during the forecast period.

The research study focuses on the global intravenous anesthetic market covering in-depth description, competitive scenario, product offerings of key vendors and business strategy adopted by competitors along with their SWOT analysis, revenue, sales and Porter's Five Forces Analysis.

Browse the full report at :

Evolving target-controlled infusion technology is providing growth opportunities to the key players :

In the intravenous anesthetic market, technologies such as target-controlled infusion (TCI) has evolved immensely from a research tool into a now-routine part of anesthesia delivery in many countries across the world. Advancement in this target-controlled infusion technology has the potential to expand the precision, efficacy, reliability, and safety of intravenous anesthesia delivery. With continuous research and development in the field of anesthesia, researchers continue to develop both new formulations of the existing agents and advanced chemical entities in strides to improve safety, efficacy, onset, predictability, and recovery profile and to minimize side effects.

Growing number of surgical procedures across various therapeutic categories are expected to drive the growth of this market:

Growth of the global intravenous anesthetic market is mainly driven by growing volume of surgical procedures across numerous therapeutic categories including orthopedic, general surgeries, cardiac, and others. Moreover, increasing development of healthcare facilities in emerging economies and advancements in the anesthesia drug delivery methods, such as jet injection, administration of general anesthesia especially in complex surgeries, and increasing adoption of intravenous anesthesia in ambulatory care are some of the additional factors contributing to the market growth and increasing market size. However, side effects associated with anesthesia drugs, lack of skilled anesthesiologist, inadequate insurance coverage and high prices of these drugs also impact the growth of intravenous anesthesia market in a negative way.

The key segments of the intravenous anesthetic market report:

The intravenous anesthetic market is segmented on the basis of drug, patient type, end user and geography. On the basis of drug, the market is segmented into barbiturates, non-barbiturates, dissociatives, and others. The patient type segment is divided into pediatric/infants, and adults. By end user the market is segmented into hospitals and clinics, specialty centers, and ambulatory centers.

Enquire for detailed ToC and Sample Pages at –

North America to dominate the global Intravenous anesthetic market in 2019

Geographic breakdown and deep analysis of each of the segments mentioned above is included for North America, Europe, Asia-Pacific, and Rest of the World. North America is expected to dominate the market by holding maximum market share of the global intravenous anesthetic market. However, Asia-Pacific is expected to experience a fastest growth during the forecast period. Huge population base, developing healthcare infrastructure, increasing number of surgical procedures due to affordability and rapidly growing pharmaceutical industry in countries like India and China are largely contributing to the market growth in this region.

Strategic collaborations enable the key players to enhance their market presence in the intravenous anesthetic market

The intravenous anesthetic market is largely competitive due to presence of enormous number of established as well as emerging players. In order to sustain in the competitive market and maintain their market position companies mainly focus on research and development as their primary growth strategy. Along with this, the players also collaborate with government as well as private organizations to develop their market presence.

Some of the major companies profiled in the report include Hospira, Novartis, Eisai, Roche, Astra Zeneca, Johnson & Johnson, GSK, Baxter, Primex Pharmaceuticals, and Abbott. 


Recent Press Release